Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Pre-SET motif family protein | 0.023 | 0.7699 | 0.7699 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.023 | 0.7699 | 0.7699 |
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.0284 | 1 | 0.5 |
Onchocerca volvulus | 0.0262 | 0.9047 | 0.5 | |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0284 | 1 | 0.5 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0284 | 1 | 1 |
Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.0284 | 1 | 0.5 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0284 | 1 | 1 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0284 | 1 | 1 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0284 | 1 | 1 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.0284 | 1 | 0.5 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0284 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0196 | 0.6237 | 0.6237 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.0284 | 1 | 0.5 |
Echinococcus multilocularis | geminin | 0.0196 | 0.6237 | 0.6237 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0284 | 1 | 1 |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0284 | 1 | 1 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.0284 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0196 | 0.6237 | 0.6237 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0284 | 1 | 1 |
Echinococcus granulosus | geminin | 0.0196 | 0.6237 | 0.6237 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0284 | 1 | 0.5 |
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.0284 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.1 uM | Inhibitory activity of the compound against the growth of wild type LCC6-WT cell line, human breast carcinoma after 74 hr drug exposure | ChEMBL. | 11814794 |
IC50 (functional) | = 0.1 uM | Inhibitory activity of the compound against the growth of wild type LCC6-WT cell line, human breast carcinoma after 74 hr drug exposure | ChEMBL. | 11814794 |
IC50 (functional) | = 1.5 uM | Inhibitory activity of the compound against the growth of drug resistant LCC6-MDR cell line, human breast carcinoma after 74 hr drug exposure | ChEMBL. | 11814794 |
IC50 (functional) | = 1.5 uM | Inhibitory activity of the compound against the growth of drug resistant LCC6-MDR cell line, human breast carcinoma after 74 hr drug exposure | ChEMBL. | 11814794 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 11814794 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.